Cargando…
Genetically Engineering a Susceptible Mouse Model for MERS-CoV-Induced Acute Respiratory Distress Syndrome
Since 2012, monthly cases of Middle East respiratory syndrome coronavirus (MERS-CoV) continue to cause severe respiratory disease that is fatal in ~35% of diagnosed individuals. The ongoing threat to global public health and the need for novel therapeutic countermeasures have driven the development...
Autores principales: | Leist, Sarah R., Cockrell, Adam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123801/ https://www.ncbi.nlm.nih.gov/pubmed/31883094 http://dx.doi.org/10.1007/978-1-0716-0211-9_12 |
Ejemplares similares
-
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome
por: Cockrell, Adam S., et al.
Publicado: (2016) -
Adaptive evolution influences the infectious dose of MERS-CoV necessary to achieve severe respiratory disease
por: Douglas, Madeline G., et al.
Publicado: (2018) -
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017) -
Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry
por: Suarez, David L., et al.
Publicado: (2020) -
Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
por: Lyoo, Kwang-Soo, et al.
Publicado: (2023)